What is it about?
This is part of an annual update on trends and advances made in the area of hip replacement treatment. This information is part of the 2016 report, which entailed a review of nearly 600 peer-reviewed studies on hip replacement that were published within the last year alone. The areas of focus include factors that may alter outcomes following THA (bearings, modularity); complications of THA (dislocaiton, tranfusion and blood management, venous Thromboembolic disease, infection, revision surgery); surgeon-specific and institutional factors in reducing risk; patient-related factors that affect outcomes (obesity, opioid dependence, smoking, psychiatric illness such as depression); and patient-reported outcomes, joint registries and bundled payment.
Featured Image
Why is it important?
Some of the new information further solidifies practices for blood conservation and detection of infection, as well as enhances knowledge of surgical approaches and modes of failure of implants. The biggest changes, though, have not been in surgical materials or techniques but in how surgeons will practice in the future with respect to outcomes. And it is important to put existing literature in perspective.
Perspectives
Many of the studies reviewed in this 2016 report lacked adequate controls, and others made claims that were either overstated or not clearly supported by the data. If surgeons are to make changes in their practices on the basis of the published literature, it is crucial that studies are appropriately designed prior to implementation and that they include appropriate control groups.
Dr. Stephen J Incavo
Houston Methodist Hospital
Read the Original
This page is a summary of: What’s New in Hip Replacement, Journal of Bone and Joint Surgery, September 2016, The Journal of Bone and Joint Surgery, Inc.,
DOI: 10.2106/jbjs.16.00702.
You can read the full text:
Resources
Contributors
The following have contributed to this page
